AI-based High Throughput Antibody Epitope Prediction and Engineering Service

Advances in AI technologies and high-throughput experimental techniques have significantly improved our ability to predict epitopes and engineer antibodies. Collaboration between bioinformatics and experimental approaches is key to the successful development of therapeutic antibodies with desired properties. At Creative Biolabs, we provide a high-throughput antibody production service for AI-based antibody epitope prediction and engineering, aiming to streamline global customers' antibody development processes and accelerate the journey from initial discovery to clinical application.

The Importance of Epitope Prediction and Engineering in Antibody Development

Antibody epitope prediction and engineering are critical components in the field of antibody development. By accurately predicting epitopes—the precise parts of an antigen that an antibody binds to—scientists can design antibodies with high specificity for their target. This helps minimize off-target effects, which is a crucial factor in developing safer and more effective therapeutic antibodies. Also, predicting epitopes accurately helps in ensuring the critical binding sites are preserved while modifying other regions to reduce immunogenicity.

Fig.1 Antigen recognition by antibodies. (Bukhari, et al., 2022)Fig.1 Antibody-antigen interaction (Paratope-epitope binding).1, 2

Our High Throughput Antibody Production Service for AI-based Antibody Epitope Prediction and Engineering

Creative Biolabs proudly offers cutting-edge high-throughput antibody production services that redefine efficiency and innovation in the field. By harnessing the power of advanced AI technology, we not only predict antibody epitopes with remarkable accuracy but also excel in engineering tailored antibodies. Our state-of-the-art facilities enable us to deliver up to 1,000 engineered antibodies within a rapid two-week timeframe, setting a new standard for high-throughput production.

Equally, our meticulously controlled experimental processes ensure that every antibody meets the highest quality standards while also providing ample opportunities for optimizing sequences to enhance stability and effectiveness. The seamless integration of our sophisticated dry and wet laboratories, paired with the expertise of our dedicated research team, empowers us to address the diverse needs of our customers and propel research projects forward with remarkable efficiency.

We sincerely invite you to reach out for more information, and we eagerly anticipate the opportunity to collaborate with global researchers to advance their work and realize scientific goals with accuracy and efficiency.

Fig.2 Service workflow. (Creative Biolabs Original)Fig.2 Our service process.

Key Features

  • Scalable high-throughput antibody production.
  • Fast delivery (~2 weeks).
  • AI technology incorporation.
  • Reproducible data.
  • Seasoned research team.

Q & A

Q1: What do customers need to provide about high throughput antibody production service for AI-based antibody epitope prediction and engineering?

A1: Customers interested in our High Throughput Antibody Production Services for AI-based antibody epitope prediction and engineering typically need to provide the following information such as: 1) Target Information: Description of the target protein or antigen; Information about the biological relevance and context of the target. 2) Epitope Specifications: Preferred epitope characteristics, including linear vs. conformational epitopes; Known or predicted residues or regions of interest. 3) Antibody Format Preferences: Desired antibody format (e.g., IgG, Fab, scFv) and any specific engineering requirements. 4) Immunization Details: Information on preferred immunization protocols such as type of immunogens, adjuvants, and immunization schedules. 5) Cell Line Preferences: Preferences for the production system or host cells (e.g., mammalian, yeast, bacterial). 6) Throughput Requirements: Number of antibodies or variants required and timeline for delivery.

Accelerate your antibody research with ease! Reach out to us today to learn more about our advanced high-throughput antibody production service for AI-based antibody epitope prediction and engineering.

References
  1. Bukhari, Syed Nisar Hussain, et al. "Machine learning techniques for the prediction of B-cell and T-cell epitopes as potential vaccine targets with a specific focus on SARS-CoV-2 pathogen: A review." Pathogens 11.2 (2022): 146.
  2. under Open Access License CC BY 4.0, without modification.

For research use only. Not intended for any clinical use.

Send Inquiry

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

  • 0
  • 0
Cart
    Go to compare

    Go to compare